This study examines the expression of cyclin K (CCNK) in endometrial cancer by comparing immunohistochemical analysis (IHC) with gene expression data from The Cancer Genome Atlas (TCGA) across endometrioid and non-endometrioid types and evaluates its correlation with patient survival outcomes. The gene discussed is CCNK; the disease is endometrial cancer.